There are numerous PR's that we are waiting on that could come any day, along with the quarterly earnings coming mid February.
Trial results from Dec. trial Potential big pharma partnerships Patent PR (that's already been granted by USPTO) Launch of Isradipine Update on other product transfers
Then in March we have the current trial concluding with the once a day oxy entering pivotal trials as well.
Market Data 
Markets 
AI
